Skip to main content
. 2020 Aug 18;223(7):1284–1294. doi: 10.1093/infdis/jiaa513

Table 1.

Patient Information and Analyte Data for Anti–Varicella Zoster Virus Antibody Titers, Amylin, Aβ Peptides, and Thioflavin-T

Patients Age Sex CSF Titer Amylin Aβ38 Aβ40 Aβ42 Thio-T
(Anti-VZV IgG) (pM) (pg/mL) (pg/mL) (pg/mL) (AU)
VZV-negative controls with stroke
 C1 64 M 0.199 6.18 595.97 1950.28 95.28 387.67
 C2 59 F 0.144 8 1448.48 4911.59 275.22 1671.17
 C3 37 F 0.076 7.04 435.9 1110.21 39.09 NM
 C4 44 M 0.0075 4.98 1831.39 5349.71 398.13 257.67
 C5 66 F 0.041 3.74 1451.63 4335.91 178.18 542.17
 C6 68 F 0.105 8.46 731.35 2120.36 98.94 207.17
 C7 26 M 0.064 4.84 673.24 2100.46 133.24 420.17
 C8 49 M 0.023 3.92 998.22 2606.64 98.94 931.67
 C9 51 M 0.001 7.68 639.8 2080.94 100.74 468.67
 C10 22 M 0.18 7.79 522.58 1847.46 99.89 126.67
 C11 78 M 0.09 3.32 1189.16 2781.59 129.32 521.17
 C12 74 M 0.031 2.16 1366.34 4166.68 268.47 684.17
 C13 46 F 0.053 8.22 954.99 2841.99 146.65 378.17
 C14 22 M 0.156 7.95 730.67 2397.42 100.74 352.67
 C15 53 M 0.035 4.31 1011.4 3212.61 158.55 347.17
 C16 69 F 0.09 3.08 1143.01 3325.35 130.67 602.67
 C17 50 F 0.142 6.14 1020.09 3039.5 152.29 NM
 C18 44 F 0.195 7.78 724.59 2435.08 124.9 564.17
 C19 65 M 0.01 4.18 294.5 787.92 23.81 637.17
 C20 19 F 0.0115 4.39 770.33 2538.79 142.29 445.67
 C21 72 F 0.091 10.61 691.75 1824.28 33.34 491.67
 C22 45 F 0.015 8.83 607.69 2031.7 73.63 111.67
 C23 42 F 0.0045 5.01 1459.22 4987.08 268.13 901.67
 C24 45 M 0.025 5.03 897.2 3072.38 175.86 1106.67
 C25 77 M 0.06 9.13 1116.97 3198.6 174.48 419.17
 C26 35 M 0.07 9.24 663.41 2442.31 129.08 507.67
 C27 70 M 0.06 5.24 1101.85 3787.31 114.09 926.67
 C28 59 F 0.007 6.11 1880.93 6026.7 451.55 454.67
 C29 45 M 0.008 11.89 577.01 2115 115.26 1294.67
 C30 58 M 0.09 9.67 756.65 2908.09 125.25 963.17
 C31 53 F 0.07 8.73 1099.1 4492.33 257.36 708.17
 C32 44 F 0.03 9.99 561.81 2134.43 103.58 54.67
 C33 35 M 0.035 12.93 1524.07 5865.8 329.37 291.67
 C34 72 F 0.09 11.23 851.85 3094.72 116.77 535.17
 C35 62 M 0.07 12.21 499.88 1800.62 75.88 253.17
 C36 59 F 0.0075 13.55 1488.71 4677.27 277.31 421.67
VZV-positive subjects with vasculopathy
 V1 53 M 4.11 12 570.61 1150.09 138.79 1808
 V2 44 F 4.8155 12.25 380.01 977.47 84.92 4135
 V3 55 M 0.73 12.58 602.03 1724.07 191.49 1361
 V4 33 M 0.35 11.13 428.26 1055.4 99.35 1143
 V5 45 M 1.048 11.33 131.52 392.68 24.82 2216
 V6 54 F 0.65 11.16 1474.15 2695.44 269.29 1126.5
 V7 33 M 0.297 7.857 618.03 1285.3 142.35 844.25
 V8 27 F 0.819 9.433 246.42 751.55 47.91 591.25
 V9 62 M 1.843 9.231 298.52 939 98.78 1037
 V10 79 F 0.213 11.05 575.75 1517.54 85 649.25
 V11 75 M 2.43 8.649 345.7 926.57 61.54 1831.75
 V12 65 M 3.7 7.439 772.39 1809.11 220.22 1430.75
 V13 78 F 3.29 9.049 922.93 2190.95 293.65 536.25
 V14 60 M 1.07 7.91 429.8 1130.73 62.4 1229.25
 V15 60 F 1.1375 8.431 1377.54 2211.27 406.36 2633.25
 V16 48 M 5.41 NM 2219.88 3987.74 543.44 2741.25

Abbreviations: AU, artificial units; CSF, cerebrospinal fluid; F, female; IgG, immunoglobulin G; M, male; NM, not measured; VZV, varicella zoster virus.